• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本心血管领域真实世界大数据研究的现状

Current status of real-world big data research in the cardiovascular field in Japan.

作者信息

Tonegawa-Kuji Reina, Kanaoka Koshiro, Iwanaga Yoshitaka

机构信息

Department of Medical and Health Information Management, National Cerebral and Cardiovascular Center, Suita, Japan.

Department of Medical and Health Information Management, National Cerebral and Cardiovascular Center, Suita, Japan.

出版信息

J Cardiol. 2023 Mar;81(3):307-315. doi: 10.1016/j.jjcc.2022.09.006. Epub 2022 Sep 17.

DOI:10.1016/j.jjcc.2022.09.006
PMID:36126909
Abstract

Real-world data (RWD) are observational data obtained by collecting, structuring, and accumulating patient information among the medical big data. RWD are derived from a variety of patient medical care and health information outside of conventional research data, and include electronic health records, claims data, registry data of disease, drug and device, health check-up data, and more recently, patient information data from wearable devices. They are currently being utilized in various forms for optimal medical care and real-world evidence (RWE) is constructed through a process of hypothesis generation and verification based on the RWD research. Together with classic clinical research and pragmatic trials, RWE shapes the learning healthcare system and contributes to the improvement of medical care. In the cardiovascular medical care of the current super-aged society, the need for a variety of RWE and the research is increasing, since the guidelines established over time and the medical care based on it cannot necessarily be the best in accordance with the current medical situation. In this review, we focus on the RWD and RWE studies in the cardiovascular medical field and outlines their current status in Japan. Furthermore, we discuss the potential for extending the studies and issues related to the use of medical big data and RWD.

摘要

真实世界数据(RWD)是通过在医学大数据中收集、整理和积累患者信息而获得的观察性数据。RWD源自常规研究数据之外的各种患者医疗保健和健康信息,包括电子健康记录、理赔数据、疾病、药物和设备登记数据、健康检查数据,以及最近来自可穿戴设备的患者信息数据。目前,它们正以各种形式被用于优化医疗保健,并通过基于RWD研究的假设生成和验证过程构建真实世界证据(RWE)。RWE与经典临床研究和实用试验一起,塑造了学习型医疗保健系统,并有助于改善医疗保健。在当前超老龄化社会的心血管医疗保健中,由于随着时间推移制定的指南以及基于该指南的医疗保健不一定符合当前医疗状况,因此对各种RWE及其研究的需求正在增加。在本综述中,我们重点关注心血管医学领域的RWD和RWE研究,并概述它们在日本的现状。此外,我们讨论了扩展这些研究的潜力以及与医学大数据和RWD使用相关的问题。

相似文献

1
Current status of real-world big data research in the cardiovascular field in Japan.日本心血管领域真实世界大数据研究的现状
J Cardiol. 2023 Mar;81(3):307-315. doi: 10.1016/j.jjcc.2022.09.006. Epub 2022 Sep 17.
2
Current Status, Challenges, and Future Perspectives of Real-World Data and Real-World Evidence in Japan.日本真实世界数据与真实世界证据的现状、挑战及未来展望
Drugs Real World Outcomes. 2021 Dec;8(4):459-480. doi: 10.1007/s40801-021-00266-3. Epub 2021 Jun 19.
3
Big data and real-world data-based medicine in the management of hypertension.基于大数据和真实世界数据的高血压管理医学。
Hypertens Res. 2021 Feb;44(2):147-153. doi: 10.1038/s41440-020-00580-3. Epub 2020 Nov 30.
4
Regulatory Approval With Real-World Data From Regulatory Science Perspective in Japan.从监管科学视角看日本基于真实世界数据的监管审批
Front Med (Lausanne). 2022 Apr 15;9:864960. doi: 10.3389/fmed.2022.864960. eCollection 2022.
5
Contemporary Databases in Real-world Studies Regarding the Diverse Health Care Systems of India, Thailand, and Taiwan: Protocol for a Scoping Review.关于印度、泰国和台湾地区多样化医疗保健系统的真实世界研究中的当代数据库:一项范围综述方案
JMIR Res Protoc. 2022 Dec 13;11(12):e43741. doi: 10.2196/43741.
6
Real-World Evidence: A Primer.真实世界证据:基础篇。
Pharmaceut Med. 2023 Jan;37(1):25-36. doi: 10.1007/s40290-022-00456-6. Epub 2023 Jan 5.
7
Real-world data to support post-market safety and performance of embolization coils: evidence generation from a medical device manufacturer and data institute partnership.支持栓塞线圈上市后安全性和性能的真实世界数据:医疗器械制造商和数据研究所合作产生的证据。
BMC Med Inform Decis Mak. 2024 Sep 19;24(1):263. doi: 10.1186/s12911-024-02659-0.
8
Developing Real-world Evidence-Ready Datasets: Time for Clinician Engagement.开发真实世界证据就绪数据集:临床医生参与的时机。
Curr Oncol Rep. 2020 Apr 16;22(5):45. doi: 10.1007/s11912-020-00904-z.
9
Data Science Methods for Real-World Evidence Generation in Real-World Data.用于真实世界数据中生成真实世界证据的数据科学方法。
Annu Rev Biomed Data Sci. 2024 Aug;7(1):201-224. doi: 10.1146/annurev-biodatasci-102423-113220. Epub 2024 Jul 24.
10
The Case for Real-world Evidence in the Future of Clinical Research on Chronic Myeloid Leukemia.真实世界证据在慢性髓性白血病临床研究未来中的应用。
Clin Ther. 2019 Feb;41(2):336-349. doi: 10.1016/j.clinthera.2018.12.013. Epub 2019 Jan 30.

引用本文的文献

1
Blood pressure control and treatment status at 1 year after the first health check-up in individuals with observed referral-level blood pressure.在观察到转诊级血压的个体中,首次健康检查后1年的血压控制和治疗状况。
Hypertens Res. 2025 Jul 25. doi: 10.1038/s41440-025-02284-y.
2
Development and validation of an algorithm for identifying patients undergoing dialysis from patients with advanced chronic kidney disease.一种用于从晚期慢性肾病患者中识别正在接受透析治疗患者的算法的开发与验证
Clin Exp Nephrol. 2025 May;29(5):650-661. doi: 10.1007/s10157-024-02614-3. Epub 2025 Jan 6.
3
Usefulness and caveats of real-world data for research on hypertension and its association with cardiovascular or renal disease in Japan.
日本真实世界数据在高血压及其与心血管或肾脏疾病相关性研究中的作用和局限性。
Hypertens Res. 2024 Nov;47(11):3099-3113. doi: 10.1038/s41440-024-01875-5. Epub 2024 Sep 11.